Adeno-associated virus type 2 in US children with acute severe hepatitis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
May 2023
Historique:
received: 11 09 2022
accepted: 10 03 2023
medline: 19 5 2023
pubmed: 31 3 2023
entrez: 30 3 2023
Statut: ppublish

Résumé

As of August 2022, clusters of acute severe hepatitis of unknown aetiology in children have been reported from 35 countries, including the USA

Identifiants

pubmed: 36996871
doi: 10.1038/s41586-023-05949-1
pii: 10.1038/s41586-023-05949-1
pmc: PMC10170441
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

574-580

Subventions

Organisme : NICHD NIH HHS
ID : R33 HD105618
Pays : United States
Organisme : NICHD NIH HHS
ID : R61 HD105618
Pays : United States

Investigateurs

Olivia Almendares (O)
Neha Balachandran (N)
Jordan E Cates (JE)
Brandi Freeman (B)
Anita Kambhampati (A)
Rachel Marine (R)
Everardo Vega (E)
Mary E Wikswo (ME)
Erin R McKeever (ER)
David Kelly (D)
Julie A Boom (JA)
Leila C Sahni (LC)
Janet A Englund (JA)
Eileen J Klein (EJ)
Mary A Staat (MA)
Maeve Marsh (M)
Erin Ricketts (E)
Joshua L Clayton (JL)
Natalia Cano (N)
Miriam Oseguera (M)
Robert Blattner (R)

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Khader, S., Foster, I., Dagens, A., Norton, A. & Sigfrid, L. Severe acute hepatitis of unknown aetiology in children-what is known? BMC Med. 20, 280 (2022).
doi: 10.1186/s12916-022-02471-5 pubmed: 35906650 pmcid: 9336128
Severe acute hepatitis of unknown aetiology in children - multi-country. WHO Disease Outbreak News https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400 (2022).
Cates, J. et al. Interim analysis of acute hepatitis of unknown etiology in children aged <10 years - United States, October 2021-June 2022. MMWR Morb. Mortal. Wkly Rep. 71, 852–858 (2022).
doi: 10.15585/mmwr.mm7126e1 pubmed: 35771734
Elsheikh, R. et al. Acute hepatitis of unknown origin in children: Behind the statistics. Hepatology https://doi.org/10.1002/hep.32682 (2022).
doi: 10.1002/hep.32682 pubmed: 35862247
Gutierrez Sanchez, L. H. et al. A case series of children with acute hepatitis and human adenovirus infection. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2206294 (2022).
doi: 10.1056/NEJMoa2206294 pubmed: 36383723
Kelgeri, C. et al. Clinical spectrum of children with acute hepatitis of unknown cause. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2206704 (2022).
doi: 10.1056/NEJMoa2206704 pubmed: 36383722
Marsh, K. et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill. 27, 2200318 (2022).
doi: 10.2807/1560-7917.ES.2022.27.15.2200318 pubmed: 35426362 pmcid: 9012090
Technical Report: Acute Hepatitis of Unknown Cause (CDC, 2022); https://www.cdc.gov/ncird/investigation/hepatitis-unknown-cause/technical-report.html .
Kager, J. et al. Fulminant adenoviral-induced hepatitis in immunosuppressed patients. Viruses 14, 1459 (2022).
doi: 10.3390/v14071459 pubmed: 35891439 pmcid: 9323657
Hierholzer, J. C. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5, 262–274 (1992).
doi: 10.1128/CMR.5.3.262 pubmed: 1323383 pmcid: 358244
Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358–378 (2019).
doi: 10.1038/s41573-019-0012-9 pubmed: 30710128 pmcid: 6927556
Meier, A. F., Fraefel, C. & Seyffert, M. The interplay between adeno-associated virus and its helper viruses. Viruses 12, 662 (2020).
doi: 10.3390/v12060662 pubmed: 32575422 pmcid: 7354565
Gao, G. et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl Acad. Sci. USA 100, 6081–6086 (2003).
doi: 10.1073/pnas.0937739100 pubmed: 12716974 pmcid: 156329
Ho, A. et al. Adeno-associated virus 2 infection in children with non-A-E hepatitis. Nature https://doi.org/10.1038/s41586-023-05948-2 (2023).
Recommendations for adenovirus testing and reporting of children with acute hepatitis of unknown etiology. CDC Health Alert Network https://emergency.cdc.gov/han/2022/han00462.asp (2022).
Chiu, C. Y. & Miller, S. A. Clinical metagenomics. Nat. Rev. Genet. 20, 341–355 (2019).
doi: 10.1038/s41576-019-0113-7 pubmed: 30918369 pmcid: 6858796
Deng, X. et al. Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance. Nat. Microbiol. 5, 443–454 (2020).
doi: 10.1038/s41564-019-0637-9 pubmed: 31932713 pmcid: 7047537
Kim, K. W. et al. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Sci. Rep. 11, 3934 (2021).
doi: 10.1038/s41598-021-83642-x pubmed: 33594223 pmcid: 7887263
Negro, F. Hepatitis D virus coinfection and superinfection. Cold Spring Harb. Perspect. Med. 4, a021550 (2014).
doi: 10.1101/cshperspect.a021550 pubmed: 25368018 pmcid: 4208707
Urban, S., Neumann-Haefelin, C. & Lampertico, P. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut 70, 1782–1794 (2021).
doi: 10.1136/gutjnl-2020-323888 pubmed: 34103404
La Bella, T. et al. Adeno-associated virus in the liver: natural history and consequences in tumour development. Gut 69, 737–747 (2020).
doi: 10.1136/gutjnl-2019-318281 pubmed: 31375600
Calcedo, R. et al. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin. Vaccine Immunol. 18, 1586–1588 (2011).
doi: 10.1128/CVI.05107-11 pubmed: 21775517 pmcid: 3165215
Chen, C. L. et al. Molecular characterization of adeno-associated viruses infecting children. J. Virol. 79, 14781–14792 (2005).
doi: 10.1128/JVI.79.23.14781-14792.2005 pubmed: 16282478 pmcid: 1287571
Hsu, H. L. et al. Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties. Nat. Commun. 11, 3279 (2020).
doi: 10.1038/s41467-020-17047-1 pubmed: 32606306 pmcid: 7327033
Chevret, L. et al. Human herpesvirus-6 infection: a prospective study evaluating HHV-6 DNA levels in liver from children with acute liver failure. J. Med. Virol. 80, 1051–1057 (2008).
doi: 10.1002/jmv.21143 pubmed: 18428148
Mellinger, J. L. et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig. Dis. Sci. 59, 1630–1637 (2014).
doi: 10.1007/s10620-014-3029-2 pubmed: 24464209 pmcid: 4250929
Brooks, B. et al. Epstein-Barr virus and human herpesvirus-6 reactivation in acute COVID-19 patients. Viruses 14, 1872 (2022).
doi: 10.3390/v14091872 pubmed: 36146679 pmcid: 9504756
Morfopoulou, S. et al. Genomic investigations of unexplained acute hepatitis in children. Nature https://doi.org/10.1038/s41586-023-06003-w (2023).
Miller, S. et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid. Genome Res. 29, 831–842 (2019).
doi: 10.1101/gr.238170.118 pubmed: 30992304 pmcid: 6499319
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
doi: 10.1093/molbev/mst010 pubmed: 23329690 pmcid: 3603318
Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
doi: 10.1093/molbev/msu300 pubmed: 25371430
QuickFacts: Alabama. US Census Bureau https://www.census.gov/quickfacts/AL (2021).
Esona, M. D. et al. Rotavirus genotype trends and gastrointestinal pathogen detection in the United States, 2014-2016: results from the New Vaccine Surveillance Network. J. Infect. Dis. 224, 1539–1549 (2021).
doi: 10.1093/infdis/jiab177 pubmed: 33822119
Heim, A., Ebnet, C., Harste, G. & Pring-Akerblom, P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70, 228–239 (2003).
doi: 10.1002/jmv.10382 pubmed: 12696109
Lyman, W. H. et al. Prospective study of etiologic agents of acute gastroenteritis outbreaks in child care centers. J. Pediatr. 154, 253–257 (2009).
doi: 10.1016/j.jpeds.2008.07.057 pubmed: 18783794
Lu, X. & Erdman, D. D. Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene. Arch. Virol. 151, 1587–1602 (2006).
doi: 10.1007/s00705-005-0722-7 pubmed: 16502282
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
doi: 10.1016/S0022-2836(05)80360-2 pubmed: 2231712
Okada, M., Ogawa, T., Kubonoya, H., Yoshizumi, H. & Shinozaki, K. Detection and sequence-based typing of human adenoviruses using sensitive universal primer sets for the hexon gene. Arch. Virol. 152, 1–9 (2007).
doi: 10.1007/s00705-006-0842-8 pubmed: 16957827
Dupuis, M. et al. Molecular detection of viral causes of encephalitis and meningitis in New York State. J. Med. Virol. 83, 2172–2181 (2011).
doi: 10.1002/jmv.22169 pubmed: 22012726
Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12, 1261–1276 (2017).
doi: 10.1038/nprot.2017.066 pubmed: 28538739 pmcid: 5902022
Naccache, S. N. et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 24, 1180–1192 (2014).
doi: 10.1101/gr.171934.113 pubmed: 24899342 pmcid: 4079973
Kearse, M. et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647–1649 (2012).
doi: 10.1093/bioinformatics/bts199 pubmed: 22543367 pmcid: 3371832
Bushnell, B. BBMap: a fast, accurate, splice-aware aligner. https://www.osti.gov/servlets/purl/1241166 (2014).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923 pubmed: 22388286 pmcid: 3322381
Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019).
doi: 10.1186/s13059-018-1618-7 pubmed: 30621750 pmcid: 6325816
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
doi: 10.1038/s41592-019-0686-2 pubmed: 32015543 pmcid: 7056644
R Core Team. R: A Language and Environmental for Statistical Computing http://www.R-project.org (R Foundation for Statistical Computing, 2013).

Auteurs

Venice Servellita (V)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Alicia Sotomayor Gonzalez (A)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Daryl M Lamson (DM)

Wadsworth Center, New York State Department of Health, David Axelrod Institute, Albany, NY, USA.

Abiodun Foresythe (A)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Hee Jae Huh (HJ)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Adam L Bazinet (AL)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Nicholas H Bergman (NH)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Robert L Bull (RL)

Federal Bureau of Investigation Laboratory Division/Scientific Response and Analysis Unit, Quantico, VA, USA.

Karla Y Garcia (KY)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Jennifer S Goodrich (JS)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Sean P Lovett (SP)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Kisha Parker (K)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Diana Radune (D)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

April Hatada (A)

California Department of Public Health, Richmond, CA, USA.

Chao-Yang Pan (CY)

California Department of Public Health, Richmond, CA, USA.

Kyle Rizzo (K)

California Department of Public Health, Richmond, CA, USA.

J Bradford Bertumen (JB)

California Department of Public Health, Richmond, CA, USA.
Centers for Disease Control and Prevention, Atlanta, CA, USA.

Christina Morales (C)

California Department of Public Health, Richmond, CA, USA.

Paul E Oluniyi (PE)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Jenny Nguyen (J)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Jessica Tan (J)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Doug Stryke (D)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Rayah Jaber (R)

Florida Department of Health, Tallahassee, FL, USA.

Matthew T Leslie (MT)

Illinois Department of Public Health, Chicago, IL, USA.

Zin Lyons (Z)

North Carolina Department of Health and Human Services, Raleigh, NC, USA.

Hayden D Hedman (HD)

Centers for Disease Control and Prevention, Atlanta, CA, USA.
South Dakota Department of Health, Pierre, SD, USA.

Umesh Parashar (U)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Maureen Sullivan (M)

Association for Public Health Laboratories, Silver Spring, MD, USA.

Kelly Wroblewski (K)

Association for Public Health Laboratories, Silver Spring, MD, USA.

M Steven Oberste (MS)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Jacqueline E Tate (JE)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Julia M Baker (JM)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

David Sugerman (D)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Caelin Potts (C)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Xiaoyan Lu (X)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Preeti Chhabra (P)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

L Amanda Ingram (LA)

Alabama Department of Public Health, Montgomery, AL, USA.

Henry Shiau (H)

University of Alabama at Birmingham, Birmingham, AL, USA.

William Britt (W)

University of Alabama at Birmingham, Birmingham, AL, USA.

Luz Helena Gutierrez Sanchez (LH)

University of Alabama at Birmingham, Birmingham, AL, USA.

Caroline Ciric (C)

Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.

Christina A Rostad (CA)

Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.

Jan Vinjé (J)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Hannah L Kirking (HL)

Centers for Disease Control and Prevention, Atlanta, CA, USA.

Debra A Wadford (DA)

California Department of Public Health, Richmond, CA, USA.

R Taylor Raborn (RT)

National Biodefense Analysis and Countermeasures Center (NBACC), Frederick, MD, USA.

Kirsten St George (K)

Wadsworth Center, New York State Department of Health, David Axelrod Institute, Albany, NY, USA.
Department of Biomedical Science, University at Albany, SUNY, Albany, NY, USA.

Charles Y Chiu (CY)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA. charles.chiu@ucsf.edu.
Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA, USA. charles.chiu@ucsf.edu.
Chan-Zuckerberg Biohub, San Francisco, CA, USA. charles.chiu@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH